Helping to Diagnose and Treat disease faster with a body of knowledge
When a patient’s health is at stake, more effective tools are critical. PerkinElmer offers advanced digital x-ray technology for diagnostics and treatment systems. We also provide the world’s leading newborn screening solutions, pioneering prenatal risk assessment, next generation diagnostic capabilities and proven cord blood stem cell services. Now, it’s possible to diagnose and treat disease earlier.
Protecting the health of babies and families
From prenatal and maternal screening to newborn genetic testing and cord blood banking, PerkinElmer is there every step of the way during one of the most exciting times in a family’s life. Through research and innovative new technologies, PerkinElmer touches over 27 million pregnancies and births every year.
Our technologies, reflected in the products and services we offer, support a pro-active approach to health care. With a comprehensive array of screening options, the mother and fetus can be screened early for genetic conditions that may impact the pregnancy or newborn. After birth, a newborn can be screened for over 50 different disorders and often with early treatment, complications can be avoided. And with the unique option of cord blood banking, with ViaCord families have the opportunity to store cord blood stem cells for future use in the treatment of nearly 80 life-threatening diseases.
PerkinElmer is changing and enhancing lives around the world. You can rely on our people and our technologies for healthy pregnancies, healthy babies, and healthy families.